I think much of the volatility we are seeing now is due to current shareholders who find themselves with a shareholding in a small biotech whose dollar value in their portfolios now equals the rest of their portfolio holdings combined. It makes sense to many to "take profits" in order to keep a diversified portfolio.
When dosing actually occurs I expect a "sell the news" effect. Providing there is not a calamitous adverse immunologic reaction in the first patient (possible I guess??), then we may then see a strong share price appreciation in the week or so following dosing as safety risk decreases.
- Forums
- ASX - By Stock
- gileads sovaldi from sa
I think much of the volatility we are seeing now is due to...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online